Reversal of isolation-rearing-induced PPI deficits by an α7 nicotinic receptor agonist

Psychopharmacology

Volumn 182, Issue 2, 2005, Pages 214-219

  Cilia, Jackie ^a   Cluderay, Jane E ^a   Robbins, Melanie J ^a   Reavill, Charlie ^a   Southam, Eric ^a   Kew, James N C ^a   Jones, Declan N C ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

7 nicotinic receptor agonist; Autoradiography; Isolation rearing; Prepulse inhibition; Schizophrenia; TaqMan

Indexed keywords

ALPHA7 NICOTINIC RECEPTOR AGONIST; N (1 AZABICYCLO[2.2.2]OCT 3 YL)[5 (2 PYRIDYL)THIOPHENE 2 CARBOXAMIDE]; NICOTINIC AGENT; NICOTINIC RECEPTOR; RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CEREBELLUM; GENE EXPRESSION; HEARING; HIPPOCAMPUS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PHENOTYPE; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REARING; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; SENSORY DYSFUNCTION; SOCIAL ISOLATION; STIMULUS; THALAMUS; WEANING;

ACONITINE; ANIMALS; BUNGAROTOXINS; MALE; NICOTINIC AGONISTS; RATS; RECEPTORS, NICOTINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOCIAL ISOLATION; STARTLE REACTION;

EID: 26844530147     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0069-5     Document Type: Article

References (35)

1. Bakshi VP, Swerdlow NR, Braff DL, Geyer MA (1998) Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine. Biol Psychiatry 43:436-445
2. Bolino F, DiMichele V, DiCocco L, Manna V, Daneluzzo E, Casacchia M (1994) Sensorimotor gating and habituation evoked by electro-cutaneous stimulation in schizophrenics. Biol Psychiatry 36:670-679
3. Bond BC, Virley DJ, Cairns NJ, Hunter AJ, Moore GB, Moss SJ, Mudg AW, Walsh FS, Jazin E, Preece P (2002) The quantification of gene expression in an animal model of brain ischemia using TaqMan real-time RT-PCR. Brain Res Mol Brain Res 106(1-2):101-116
4. Braff DL (1989) Sensory input deficits and negative symptoms in schizophrenic patients. Am J Psychiatr 146:1006-1011
5. Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47:181-188
6. Braff DL, Grillon C, Geyer MA (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206-215
7. Braff DL, Swerdlow NR, Geyer MA (1995) Gating and habituation deficits in the schizophrenia disorders. Clin Neurosci 3:131-139
8. Brenner CA, Edwards CR, Carrol CA, Kieffaber PD, Hetrick WP (2004) P50 and acoustic startle gating are not related in healthy participants. Psychophysiology 41:702-708
9. Cilia J, Reavill C, Hagan JJ, Jones DNC (2001) Long-term evaluation of isolation-reared prepulse inhibition deficits in rats. Psychopharmacology 156:327-337
10. Cilia J, Hatcher PD, Reavill C, Jones DNC (2005) Long-term evaluation of isolation-reared prepulse inhibition deficits in rats: an update. Psychopharmacology, available on-line; DOI: 10.1007/s00213-004-2139-5
11. 3H] methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology 38:679-690
12. De Filippi G, Broad LM, Zwart R, Baldwinson T, Felthouse C, McPhie G, Pearson K, Craig P, Broadmore R, Bell F, Cases M, Keenan M, Baker SR, Boot J, Sher E (2002) Pharmacological characterisation and in vitro physiological effects of new 7 nicotinic acetylcholine receptor agonists. Society for Neuroscience, Washington, DC, program no. 137.5
13. Freedman R, Hal M, Adler LE, Leonard S (1995) Evidence in post-mortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 38:22-33
14. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156(2-3):117-154
15. Grottick AJ, Trube G, Corrigall WA, Huwyler J, Malherbe P, Wyler R, Higgins GA (2000) Evidence that nicotinic α7 receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. J Pharmacol Exp Ther 294:1112-1119
16. Hoffman HS, Ison JR (1980) Reflex modification in the domain of startle. I. Some empirical findings and their implication for how the nervous system processes sensory input. Psychol Rev 87:175-189
17. Leonard S, Gault J, Adams C, Breese CR, Rollins Y, Adler LE, Olincy A, Freedman R (1998) Nicotinic receptors, smoking and schizophrenia. Restor Neurol Neurosci 12:1-7
18. Leonard S, Gault J, Hopkins J, Logel J, Vianzon R, Short M, Drebin C, Berger R, Venn D, Sirota P, Zerbe G, Olincy A, Ross RG, Adler LE, Freedman R (2002) Association of promoter variants in the a7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry 59:1085-1096
19. Livak KJ (1999) Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14:143-149
20. Luntz-Leybman V, Bickford PC, Freedman R (1992) Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res 587:130-136
21. Martin LF, Kem WR, Freedman R (2004) Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology 174:54-64
22. McEvoy JP, Allen TB (2002) The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndrome. Curr Drug Target CNS Neurol Disord 1:433-442
23. Medhurst AD, Harrison DC, Read SJ, Campbell CA, Robbins MJ, Pangalos MN (2000) The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J Neurosci Methods 98(1):9-20
24. 3H]methyllycaconitine binding sites following continuous infusion of nicotine, without changes of α7 or α6 subunit mRNA: an autoradiography and in situ hybridization study in rat brain. Eur J Neurosci 16:1633-1646
25. Nakato K, Morita T, Wanibuchi F, Yamaguchi T (1997) Antipsychotics restored but antidepressants and anxiolytics did not restore prepulse inhibition (PPI) deficits in isolation-reared rats. Soc Neurosci Abstr 23:1855
26. O'Neill MJ, Moore NA, McKinzie DL, Keenan M, Wishart G, Shannon HE, Murray TK, O'Neill MF, Tree B, Iyengar S, Hart J, Shaw D, Simmons RMA, Kalar AB, Miles C, Baker SR, Sher E, Tricklebank MD (2002) Behavioural profiling of two potent alpha-7 nicotinic acetylcholine receptor agonists. Society for Neuroscience, Washington, DC, program no. 137.6
27. O'Neill HC, Rieger K, Kem WR, Stevens KE (2003) DMXB, an α7 nicotinic agonist, normalizes auditory gating in isolation-reared rats. Psychopharmacology 169:332-339
28. Parwani A, Duncan EJ, Bartlett E, Madonick SH, Efferen TR, Rajan R, Sanfilipo M, Chappell PB, Chakravorty S, Gonzenbach S, Ko GN, Rotrosen JP (2000) Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry 47:662-669
29. Simosky JK, Stevens KE, Freedman R (2002) Nicotinic agonists and psychosis. Curr Drug Target CNS Neurol Disord 1:149-162
30. Stevens KE, Freedman R, Collins AC, Hall M, Leonard S, Marks MJ, Rose GM (1996) Genetic correlation of inhibitory gating of hippocampal auditory evoked response and α-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology 15(2):152-162
31. Suemaru K, Yasuda K, Umeda K, Araki H, Shibata K, Choshi T, Hibino S, Gomita Y (2004) Nicotine blocks apomorphine-induced disruption of prepulse inhibition of the acoustic startle in rats: possible involvement of central nicotinic α7 receptors. Br J Pharmacol 142:843-850
32. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51:139-153
33. Swerdlow NR, Braff DL, Geyer MA (2000) Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 11:185-204
34. Weiss IC, Feldon J (2001) Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review. Psychopharmacology 156(2-3):305-326
35. 3H]methyllycaconitine in the mouse brain. Eur J Neurosci 11:2689-2696